Skip to content
PeptideWiki.bio

Metabolic

Dulaglutide

Also called Trulicity

InjectableEvidence AOnce a week
Half-life
113hours
Typical vial
3 / 4.5mg
Research amounts
0.75–4.5mg

per administration

Common schedule
Once a week
Tested in people

A human trial worked out how much to take and how often, so a dosing schedule is shown.

Licensed as a medicine in the US and EU.

Quick start

Dulaglutide at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.

Typical dose
0.75–4.5 mg per administration
How often
Once a week
Where
Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
Time to steady level
~23.5 days — about five half-lives
Storage
Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details

A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.

Key properties

Molecular reference data.

Formula
C2646H4044N704O836S18
Mol. weight
59,670.63 Da
CAS
923950-08-7

Work out your draw

These numbers are a starting point — change any of them.

Vial label

Copy this into your label printer.

Published research contexts for Dulaglutide describe 0.754.5 mg per administration. Descriptive only, not a recommendation.

About 4.7 days. Built as a GLP-1 analog fused to a modified IgG4 Fc fragment, which is what stretches elimination to several days and supports once-weekly dosing.

Dosing schedule

How Dulaglutide is commonly stepped up, for reference only.

These are commonly-discussed research protocols shared for educational reference. This is not medical advice and is not a substitute for guidance from a qualified professional.

PhaseAmountFrequencyRoute
Weeks 1–4Starting step.0.75 mgOnce weeklySubQ
Weeks 5+1.5 mgOnce weeklySubQ
After ≥4 weeks3 mgOnce weeklySubQ
After ≥4 more weeksHighest step in AWARD-11; step up no sooner than every 4 weeks.4.5 mgOnce weeklySubQ

Modelled level — once a week

1× is the peak after a single dose.

Steady-state peak
1.49× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
23.5days

About five half-lives

Administrations
1/ week

Where these numbers come from

  • AWARD-11 (Frías JP et al., Diabetes Care 2021;44:765)Once-weekly dulaglutide 3.0 mg and 4.5 mg compared with 1.5 mg over 52 weeks in adults with type-2 diabetes.

Next steps